10 years of living and managing type 1 diabetes; lessons learned
By Guest Contributor | November 30, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday: Progress in fight against diabetes is one more thing to be thankful for this year
By Nicole Longo | November 21, 2016
30 million. 1.4 million. 11 million. 86 million. These numbers on their own may mean nothing, but in the context of diabetes, they paint an entirely different picture. More than 30 million...
Read More
Reflecting on terrific progress in treating diabetes
By Bill Chin, M.D. | November 17, 2016
There is no doubt that diabetes is a complex disease to diagnose and treat. That’s something I’ve seen firsthand as an endocrinologist. Over the years, I treated a number of patients that had a...
Read More
New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives
By Hannah Mooney | November 14, 2016
Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the...
Read More
Burden on patients: Insurance benefit design’s impact on patient access to medicines
By Allyson Funk | June 30, 2016
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents...
Read More
New report celebrates a decade of progress in chronic diseases
By Holly Campbell | February 25, 2016
In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...
Read More
Patients and researchers say “we’re fighting back” in new “From Hope to Cures” ads
By Ieva M. Augstums | February 8, 2016
Diagnosed with type 1 diabetes at a young age, five-year-old Rhys has not let his diagnosis be his destiny. He enjoys life to the fullest, from playing sports to having treats at a friend’s...
Read More
Ask About Adherence: Q&A with Dr. Helaine Resnick on diabetes care
By Samantha Dougherty | December 17, 2015
Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Helaine E. Resnick, PhD, MPH about her recently published literature review...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | August 28, 2015
Developing New Medicines: Innovative medicines offer hope to patients and bring value to the health care system, but developing these new treatments is a rigorous, lengthy and costly process, and...
Read More
Burden on Patients: 5 Questions on Access to Diabetes Medicines in Health Exchange Plans
By Allyson Funk | August 27, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
